Archives

Safety Assessment of Palm Tocotrienol (EVNol SupraBio™) in Subjects with Metabolic Syndrome

A randomized, double-blind, cross-over and placebo-controlled clinical trial shows that in subjects with metabolic syndrome, supplementation with 400mg palm tocotrienol complex for 14 days are well-tolerated, with no signs of any adverse health events of blood profile (e.g. haematoxicity) and liver functions (e.g. hepatotoxicity). These results may contribute to the scientific community in the establishment... View Article